Fingerprint
Dive into the research topics of 'Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis
K. Gowin, H. Kosiorek, A. Dueck, J. Mascarenhas, R. Hoffman, C. Reeder, J. Camoriano, R. Tibes, K. Gano, J. Palmer, R. Mesa
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations